B3cnewswire.com

B3c Newswire. The specialized life science and biotech press release distribution service

Today's B3cnewswire.com headlines: Observe fresh posts and updates on B3c Newswire. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or B3cnewswire.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to B3c Newswire

Subscribe to related news

RedHill Announces Approval of a European Patent Supporting RHB-104 for Multiple Sclerosis
via ip

RedHill Biopharma (NASDAQ: RDHL) (TASE: RDHL) today announced that it has received from the European Patent Office a Notice of Intention to Grant for a new patent covering the use of RHB-104 in the treatment of multiple sclerosis. Upon grant by the European...
InPlay from Briefing.com
via whotrades.olanola

------ Major European indices trade lower across the board with Germany's DAX (-2.0%) trailing the region. Elsewhere, European Central Bank member Benoit Coeure said that debt relief for Greece is no longer a subject of debate with bailout negotiations...
RedHill and Concordia sign co-promotion agreement for Donnatal drug promotion
via pharmaceutical-technology

Israeli-based RedHill Biopharma has signed a co-promotion agreement with Canadian-based Concordia International’s subsidiary to acquire certain US promotion rights for the prescription oral drug Donnatal that is used with other drugs to treat irritab...
RedHill Biopharma Announces Collaboration With Germany’s Fraunhofer Institute for Oncology Drug RP101
via indonesianewsgazette

TEL-AVIV, Israel, Feb. 08, 2016 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), an Israeli biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage,...
RedHill Biopharma Announces Acceptance of Phase III Trial Application in Europe with RHB-104 for Crohn's Disease
via military-technologies

TEL-AVIV, Israel, June 16, 2015 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) ("RedHill" or the "Company"), an Israeli biopharmaceutical company focused on late clinical-stage, proprietary, orally-administered, small molecule drugs...

B3cnewswire.com popular pages

The Life Science and Biotech Newswire - Home

The specialized life science and biotech press release distribution service
Pharmaceutical Biotechnology

Targeted press release (PR) distribution service for the biopharmaceutical industry.

FuturaGene’s Eucalyptus Is Approved for Commercial Use in Brazil

The Brazilian National Technical Commission on Biosafety (CTNBio) today approved the commercial use of the yield enhanced eucalyptus developed by FuturaGene. Field experiments conducted since 2006 at ...